1 recruiting, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Avascular Necrosis: new trials by email Literature Review of Avascular Necrosis trials Research Report on Avascular Necrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Alendronate Sodium - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Recruiting | University of California, Davis | 30 | 2026-03-09 | 2026-07-16 |
| Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty: Placebo, Lacosamide - Osteoarthritis, Rheumatoid Arthritis | Phase 2 | Withdrawn | Indiana University | 2014-11-01 | 2016-08-26 | |
| Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus Atorvastatin, MRI, Venipuncture, Placebo - Avascular Necrosis | Phase 2 | Terminated | NYU Langone Health | 43 | 2002-11-01 | 2018-11-23 |
Osteonecrosis (3) · Anemia, Sickle Cell (1) · Arthritis, Rheumatoid (1) · Legg-Calve-Perthes Disease (1) · Osteoarthritis (1)
Bone Diseases (3) · Musculoskeletal Diseases (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Arthritis (1) · Autoimmune Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Femur Head Necrosis (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1)
Alendronate (1) · Atorvastatin (1) · Lacosamide (1) · Magnetic Resonance Spectroscopy (1) · Phlebotomy (1)
Indiana University (1) · NYU Langone Health (1) · University of California, Davis (1)
United States (3)
Bryan M Sakamoto, M.D., PhD (1) · Howard M Belmont, M.D. (1) · Oyebimpe O Adesina, MD, MS (1)
K23HL148310 (1)